Rare diseases
Investigational molecules
Locations
Study on the Effectiveness and Safety of Sonelokimab for Adults with Moderate to Severe Hidradenitis Suppurativa
GermanyComparison of allogeneic stem cell transplantation versus conventional therapy in patients with multiple myeloma who relapsed after first-line therapy
GermanyStudy of Obinutuzumab as First-Line Treatment for Adult Patients with Marginal Zone Lymphoma Who Are Not Eligible for Local Therapy
GermanyStudy on Copanlisib and Rituximab for Patients with Marginal Zone Lymphoma Needing Treatment After Local Therapy Failure or Relapse
GermanyStudy of Copanlisib with Rituximab and CHOP for Untreated Diffuse Large B-Cell Lymphoma in Patients Aged 18-80
GermanyComparison of Post-Transplant Cyclophosphamide versus Anti-T Lymphocyte Immunoglobulin for Prevention of Graft versus Host Disease in Patients Receiving Unrelated Donor Transplantation
GermanyStudy of Sotatercept for Newly Diagnosed Intermediate- and High-risk Pulmonary Arterial Hypertension Patients
GermanyLong-term Study of Sotatercept for Adults with Pulmonary Arterial Hypertension (PAH)
GermanyStudy of decitabine and cedazuridine combination in patients with lower-risk myelodysplastic syndromes
GermanyStudy Comparing Bomedemstat and Hydroxycarbamide for Patients with Essential Thrombocythemia
GermanyStudy Comparing Ribociclib and Endocrine Therapy to Chemotherapy for Patients with Intermediate-Risk HR+/HER2- Early Breast Cancer
GermanyStudy on Nimodipine for Hearing Preservation in Patients Undergoing Acoustic Schwannoma Surgery
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.
